Constipation Chronic Idiopathic Clinical Trial
Official title:
Do the Symptoms of Chronic Constipation Improve With a Primary Care Programme Based on Behavioural Re-education and Abdominal Massage? A Randomised Control Trial
Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term.
Background: Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term. Method: Randomised clinical trial. Participants: people with constipation in the region of L'Anoia, Catalonia. There will be 3 groups: the control group (CG), behavioural intervention group (BIG) and behavioural intervention and massage group (BIMG). Constipation will be assessed with the Bristol scale, Rome IV Criteria and the number of laxatives; and quality of life with the CVE-20 Questionnaire. Participants will be proposed from Primary Care Centres in the region of L'Anoia, Catalonia, Spain. Inclusion criteria: - Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration. - Understanding Catalan, Spanish or English. Exclusion criteria: - Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases. - Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex. - Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure. - Meeting any absolute contraindication criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures. - Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project. Discussion: Research is needed on conservative, non-pharmacological treatment to try to reduce one of the main conditions affecting public health, and thus reduce the possible illnesses associated with constipation and reduce costs to the health system. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05129618 -
Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)
|
N/A | |
Suspended |
NCT04306939 -
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
|
||
Recruiting |
NCT06414525 -
Effect of Abdominal Massage Versus Visceral Manipulation on Constipation
|
N/A | |
Completed |
NCT06082622 -
Evaluation of the Triple Management Program in the Management of Functional Chronic Constipation in Children
|
N/A | |
Recruiting |
NCT04148248 -
A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation
|
||
Active, not recruiting |
NCT05923723 -
Efficacy of a Dietary Intervention for the Treatment of Constipation in Institutionalized Older Adults. Medellín, 2023-2024.
|
N/A | |
Completed |
NCT05036369 -
Vibrant Capsule vs. Placebo for Patient Suffering From Constipation
|
N/A | |
Not yet recruiting |
NCT06413368 -
Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study
|
Phase 2/Phase 3 | |
Completed |
NCT04262752 -
MOWOOT Device to Treat Constipation in Adults
|
N/A | |
Not yet recruiting |
NCT04666155 -
MOWOOT Device Treatment for Adults With Chronic Constipation
|
N/A | |
Not yet recruiting |
NCT06349031 -
Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction
|
Phase 4 |